| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| ERDA1 |
|
expanded repeat domain, CAG/CTG 1
|
|
|
0.736 |
0.154 |
| DISC2 |
|
disrupted in schizophrenia 2
|
|
|
0.716 |
0.192 |
| DAOA-AS1 |
|
DAOA antisense RNA 1
|
|
|
0.729 |
0.154 |
| MIR18A |
|
microRNA 18a
|
|
|
0.520 |
0.846 |
| MDD1 |
|
Major depressive disorder
|
|
|
0.682 |
0.308 |
| BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
| P2RX5-TAX1BP3 |
|
P2RX5-TAX1BP3 readthrough (NMD candidate)
|
|
|
0.588 |
0.769 |
| TEMPS |
|
Temple syndrome
|
|
|
0.780 |
0.154 |
| LOC110806262 |
|
solute carrier family 6 member 4 gene promoter
|
|
|
0.626 |
0.423 |
| STIN2-VNTR |
|
serotonin transporter intronic VNTR enhancer
|
|
|
0.636 |
0.538 |
| MCIDAS |
D6RGH6
|
multiciliate differentiation and DNA synthesis associated cell cycle protein
|
|
1.3E-02 |
0.566 |
0.769 |
| ARNTL |
O00327
|
aryl hydrocarbon receptor nuclear translocator like
|
Transcription factor
|
0.99 |
0.510 |
0.885 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
| FAAH |
O00519
|
fatty acid amide hydrolase
|
|
4.4E-11 |
0.545 |
0.692 |
| KRIT1 |
O00522
|
KRIT1 ankyrin repeat containing
|
|
6.9E-04 |
0.500 |
0.808 |
| CXCR6 |
O00574
|
C-X-C motif chemokine receptor 6
|
G-protein coupled receptor
|
5.7E-05 |
0.448 |
0.885 |
| IMPA2 |
O14732
|
inositol monophosphatase 2
|
Enzyme
|
1.1E-03 |
0.695 |
0.385 |
| PPP1R2C |
O14990
|
PPP1R2C family member C
|
Enzyme modulator
|
|
0.478 |
0.846 |
| VGF |
O15240
|
VGF nerve growth factor inducible
|
|
0.57 |
0.626 |
0.538 |
| CLOCK |
O15516
|
clock circadian regulator
|
|
1.00 |
0.463 |
0.885 |
| GPR42 |
O15529
|
G protein-coupled receptor 42 (gene/pseudogene)
|
G-protein coupled receptor
|
5.1E-02 |
0.475 |
0.846 |
| P2RX6 |
O15547
|
purinergic receptor P2X 6
|
Ion channel
|
4.5E-09 |
0.599 |
0.769 |
| FOXO3 |
O43524
|
forkhead box O3
|
|
0.99 |
0.431 |
0.808 |
| HCRT |
O43612
|
hypocretin neuropeptide precursor
|
|
2.9E-02 |
0.500 |
0.808 |